A Genetic Approach in the Evaluation of Short Stature


TÜRKYILMAZ A., Donmez A. S., Cayir A.

Eurasian Journal of Medicine, vol.54, 2022 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 54
  • Publication Date: 2022
  • Doi Number: 10.5152/eurasianjmed.2022.22171
  • Journal Name: Eurasian Journal of Medicine
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Keywords: Genetics, growth disorders/genetics, genetic predisposition to disease, COPY NUMBER VARIANTS, GROWTH-FACTOR RECEPTOR-3, IDIOPATHIC SHORT STATURE, MULTIPLE EPIPHYSEAL DYSPLASIA, LERI-WEILL DYSCHONDROSTEOSIS, INTELLECTUAL DISABILITY, HETEROZYGOUS MUTATIONS, B NPR2, CHILDREN, PATIENT
  • Karadeniz Technical University Affiliated: Yes

Abstract

© 2022.Short stature is considered a condition in which the height is 2 standard deviations below the mean height of a given age, sex, and population group. Human height is a polygenic and heterogeneous characteristic, and its heritability is reported to be approximately 80%. More than 600 variants associated with human growth were detected in the genome-wide association studies. Rare and common variants concurrently affect human height. The rare variations that play a role in human height determination and have a strong impact on protein functions lead to monogenic short stature phenotypes, which are a highly heterogeneous group. With rapidly developing technologies in the last decade, molecular genetic tests have begun to be used widely in clinical genetics, and thus, the genetic etiology of several rare diseases has been elucidated. Identifying the genetic etiology underlying idiopathic short stature which represents phenotypically heterogeneous group of diseases ranging from isolated short stature to severe and syndromic short stature has promoted the understanding of the genetic regulation of growth plate and longitudinal bone growth. In cases of short stature, definite molecular diagnosis based on genetic evaluation enables the patient and family to receive genetic counseling on the natural course of the disease, prognosis, genetic basis, and recurrence risk. The determination of the genetic etiology in growth disorders is essential for the development of novel targeted therapies and crucial in the development of mutation-specific treatments in the future.